| Cargill, Chris (Sosei 202307 CEO of Sosei Heptares) |
Chief Executive Officer (CEO) |
Sosei (Group) |
Japan |
| Carius, Wolfram (Bayer 202012 Head of Cell + Gene Therapy Unit before Boehringer) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Carl, Peter (SAFIA Technologies 202305 Managing Director + Co-Founder) |
Managing Director |
SAFIA Technologies GmbH |
Germany |
| Carle, Vanessa (Forbion 202203– Associate before PharmaVentures + EPFL) |
venture capital |
Forbion (Group) |
Netherlands |
| Carlisle, Ileana (Biotest 201605 CEO of Biotest Pharmaceuticals Corp) |
Chief Executive Officer (CEO) |
Grifols (Group) |
United States (USA) |
| Carlson, Eric (Portein Metrics 201510 CBO) |
Chief Business Officer (CBO) |
Insightful Science (Group) |
United States (USA) |
| Carlson, Margaret K. (Alira Health 202005 CFO) |
Chief Financial Officer (CFO) |
Alira Health (CMC Consulting Boston) (Group) |
United States (USA) |
| Carmagnol, Caroline (Alize RP 201107 CEO + Founder) |
Chief Executive Officer (CEO) |
Alize RP (Public Relations) |
France |
| Carman, Bill (Fast Track Diagnostics 201712 CEO) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Malta |
| Carmona, Jose I. (Pepe) (ADC Therapeutics 202212– CFO before Rubius Therapeutics + Radius Health + Innocoll + Novartis) |
Chief Financial Officer (CFO) |
ADC Therapeutics (Group) |
Switzerland |
| Carnot, Lionel (EarlyBird 202010 Partner + Bay City Capital 201608 Managing Director) |
Managing Director |
Bay City Capital LLC |
United States (USA) |
| Caroli, Luis Eduardo (BioZeus 201409 CEO) |
Chief Executive Officer (CEO) |
BioZeus Desenvolvimento de Produtos Biofarmacêuticos S.A. |
Brazil |
| Carouge, Dominique (Sanofi 201802– EVP Head of Business Transformation joined Sanofi 2009 before Ernst & Young) |
Business Development Manager / Strategy Manager |
Sanofi (Group) [since May 2011] |
France |
| Carr, Grant (Albany Molecular 201702 Senior Director Lead Discovery) |
President/Director/Head Business Group/Unit/Division |
Curia (Group) |
United States (USA) |
| Carrier, Mark (Hamilton 201303 Market Segment Manager at Hamilton Company) |
Product Manager (personnel) |
Hamilton (Group) |
United States (USA) |
| Carrillo, Cristina (ResearachGate 202307) |
n. a. |
ResearchGate (Group) |
Germany |
| Carroll, Darren (Polaris Partners 202012) |
Investment Manager |
Polaris Partners (Polaris Ventures) |
United States (USA) |
| Carroll, Jill (GSK 201810 Principal at SR One) |
Principal (venture capital) |
SR One (Group) |
United States (USA) |
| Carstensen, Peter Harry (Schleswig-Holstein (govt) 201007 Minister President + CDU) |
Minister |
Schleswig-Holstein (govt region) |
Germany |
| Cartellieri, Simone (GALAB Technologies) |
n. a. |
GALAB Technologies GmbH |
Germany |
| Carter, Adrian (Boehringer Ingelheim 201207 Corporate VP Global Research Networking) |
Business Development Manager / Strategy Manager |
Boehringer Ingelheim (Group) |
Germany |
| Carter, Stephen A. (Informa 201401– CEO before non-executive Board Director) |
Chief Executive Officer (CEO) |
Informa plc (Group) |
Switzerland |
| Caruso, Anthony (febit 200705– VP Informatics before Lion) |
n. a. |
Hummingbird Diagnostics GmbH |
Germany |
| Carvell, John (Aber Instruments 201302 Sales + Marketing Director) |
Sales Manager / Marketing Manager |
Aber Instruments (Group) |
United Kingdom (GB) |
| Casari, Georg (CeMM 201211 Director + Haplogen 201211 CEO + founder before Oridis Biomed + Cellzome + Lion Bioscience) |
Managing Director |
Haplogen Bioscience GmbH |
Austria |
| Casarosa, Paola (Boehringer 202401– Managing Director Innovation Unit before Global Head Therapeutic Areas joined 2007) |
Business Development Manager / Strategy Manager |
Boehringer Ingelheim Innovation Unit |
Germany |
| Cascella, Chris (Thermo Fisher 202109 General Manager Inorganic MS, Chromatography + MS) |
General Manager (management) |
Thermo Fisher (Group) |
United States (USA) |
| Cascella, Robert (Philips SVP Diagnosis + Treatment business before Hologic CEO) |
Chief Executive Officer (CEO) |
Philips (Group) |
Netherlands |
| Casebourne, Charlotte (Theolytics 202107 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Theolytics Ltd. |
United Kingdom (GB) |
| Casel, Hans-Peter (Sartorius 201012 Managing Director of Sartorius Stedim Systems GmbH) |
Managing Director |
Sartorius (Group) |
Germany |
| Casilag, Fiordiligie (Pepperprint 202206 Head of Marketing + Science Communications) |
Sales Manager / Marketing Manager |
Pepperprint GmbH |
Germany |
| Casper, Marc N. (Thermo Fisher 200910– CEO before 200805– COO joined Thermo 12/01 before Kendro CEO before Dade Behring) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
United States (USA) |
| Caspi, Guy (Deep Instinct 202104 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Deep Instinct (Group) |
United States (USA) |
| Cassani, Danilo (Takeda 201502 Area Head Near East + Middle East + Africa) |
Regional manager |
Takeda (Group) |
Japan |
| Castanheira, Mariana (JMI Laboratories 201206 Research Scientist) |
Researcher (industry) |
JMI Laboratories (JMI Labs) |
United States (USA) |
| Castorina, Maurizio (Zambon 201511 CEO) |
Chief Executive Officer (CEO) |
Zambon (Group) |
Italy |
| Castrillo, José Luís (Genetadi Biotech 201507 CEO) |
Chief Executive Officer (CEO) |
Genetadi Biotech S.L |
Spain (España) |
| Caswell, Mark (Rentschler 202207– VP Site Head for US Facility before Lonza Biologics + Sanofi Genzyme) |
President/Director/Head Business Group/Unit/Division |
Rentschler (Group) |
United States (USA) |
| Catenhusen, Wolf Michael |
n. a. |
Germany (govt) |
Germany |
| Catsicas, Stefan (SkyViews Life Science 202012 Managing Partner) |
Managing Partner (investment firm) |
SkyViews Life Science S.A. |
Switzerland |
| Cattaneo, Roberto (Bracco 201710 Media Relations at Bracco Imaging SpA) |
Public Relations Manager / Investor Relations Manager |
Bracco (Group) |
Italy |
| Caulder, Jerry (Finistere Ventures 201502 Chairman) |
Venture Partner |
Finistere Partners LLC (Finistere Ventures) |
United States (USA) |
| Cautreels, Werner (Selecta Biosciences 2012 CEO before CEO of Solvay Pharmaceuticals before Sanofi + Sterling-Winthrop) |
Chief Executive Officer (CEO) |
Selecta Biosciences (Group) |
United States (USA) |
| Cavalleri, Andrea (Max Planck 201211– Founding Director of MPI for Structure and Dynamics of Matter) |
President/Director/Head Business Group/Unit/Division |
Max Planck Society for the Advancement of Science |
Germany |
| Cavalli, Fabio (MondoBiotech 200901 CEO) |
Chief Executive Officer (CEO) |
Relief Therapeutics (Group) |
Switzerland |
| Cavanagh, Shawn (Lonza Bioscience 200807 President) |
n. a. |
Lonza (Group) |
Switzerland |
| Cavdar, Avni (Zivak Technologies 201310 President) |
President/Director/Head Business Group/Unit/Division |
Zivak Technologies (TR) |
Turkey |
| Cawthorn, Robert (Actelion –201109 existent Chairman of Board Directors TO LEAVE BOARD in 2012) |
Board member, non-executive |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
| Cayli, Aziz (Cellca GmbH 201201 Member of Shareholder Board before Managing Director ) |
Board member, non-executive |
Sartorius (Group) |
Germany |
| Caßing, Anke (High-Tech Gründerfonds 202001) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Ceh, Borut (Labena 201506 CEO) |
Chief Executive Officer (CEO) |
Labena d.o.o. |
Slovenia |
| Cerff, R. |
n. a. |
Technical University Braunschweig (TU Braunschweig) |
Germany |
| Cevc, Gregor (IDEA AG –200710–201002 CEO resigned 2/10) |
Chief Executive Officer (CEO) |
IDEA AG |
Germany |
| Cezanne, Andreas (Merck (DE) 202101 Head of Corporate Media Relations) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
| Chambers, Michael (Aldevron 201805 CEO) |
Chief Financial Officer (CFO) |
Aldevron (Group) |
United States (USA) |
| Chambon, Benjamin (Alira Health 202004 Chief Commercial Officer + Co-Founder) |
Chief Commercial Officer (CCO) |
Alira Health (CMC Consulting Boston) (Group) |
United States (USA) |
| Chambré, Peter (Cambridge Antibody 200204– CEO before Celera Genomics COO before Bespak CEO) |
Chief Executive Officer (CEO) |
AstraZeneca (Group) |
United Kingdom (GB) |
| Chan, Hing Kin (ProBioGen 200411) |
n. a. |
Minapharm (Group) |
Germany |
| Chapman, Paul (Quanterix 201207– CEO before EMD Millipore + Roche) |
Chief Executive Officer (CEO) |
Quanterix (Group) |
United States (USA) |
| Charles, Susan (Sue) (Instinctif 201611 Managing Partner Life Sciences before College Group + Northbank + HCC De Facto) |
Public Relations Manager / Investor Relations Manager |
Instinctif Partners (Group) |
United Kingdom (GB) |
| Charlon, Vincent (Anergis 201103 CEO) |
Chief Executive Officer (CEO) |
Anergis S.A. |
Switzerland |
| Charpentier, Emmanuelle (Helmholtz 201412 Professor at HZI) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Chasseloup de Chatillon, Jean-Baptiste (Sanofi 201810– CFO joined 9/18 before PSA Group) |
Chief Financial Officer (CFO) |
Sanofi (Group) [since May 2011] |
France |
| Chatterjee, Amit (Sartorius 200910 Managing Director Sartorius India) |
Managing Director |
Sartorius (Group) |
India |
| Chatziathanasiou, Mathäos (MZ-Analysentechnik 201402 Managing Director) |
Managing Director |
MZ-Analysentechnik GmbH |
Germany |
| Chaud, Bernard (Global Bioenergies 201702 Head of Industrial Strategy) |
Business Development Manager / Strategy Manager |
Global Bioenergies (Group) |
France |
| Chaurushiya, Mira (5AM Ventures 202111 Partner) |
Partner (venture partner) |
5AM Ventures (US) |
United States (USA) |
| Chaya, Dina (Onega Funds 202109) |
Investment Manager |
Omega Funds (Group) |
United States (USA) |
| Cheek, Julia (EverlyWell 201907 CEO + Founder) |
Chief Executive Officer (CEO) |
EverlyWell Inc. |
United States (USA) |
| Chemnitz, Jan (Provirex 201911– Managing Director) |
Managing Director |
Provirex Genome Editing Therapies GmbH |
Germany |
| Chen, Benjamin (Immune Targeting Systems Ltd 201501 CEO) |
Chief Executive Officer (CEO) |
Altimmune (Group) |
United Kingdom (GB) |
| Chen, Elbert (Cytena 201907 CFO of Cytena Bioprocess Solutions Co Ltd) |
Chief Financial Officer (CFO) |
Bico (Group) |
Taiwan |
| Chen, Henry (Delos Capital 2014– Managing Partner + Co-Founder) |
n. a. |
Delos Capital (Delos Advisors Ltd.) |
China |
| Chen, Irene (DKSH 201804 Group Communications Manager of Business Unit Technology) |
Public Relations Manager / Investor Relations Manager |
DKSH (Group) |
Switzerland |
| Chen, Shuqi (IQuum 201404 CEO + Co-founder) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Chen, Zhisheng (Chris) (WuXi Pharmatech 201812 CEO of WuXi Biologics) |
Chief Executive Officer (CEO) |
WuXi PharmaTech (Group) |
China |
| Cheng, Jing (CapitalBio 200504 CEO + CTO) |
Chief Executive Officer (CEO) |
CapitalBio (Group) |
China |
| Cheng, Yong-Sheng (PixelBiotech GmbH 201904– Managing Director + Co-Founder) |
Managing Director |
PixelBiotech GmbH |
Germany |
| Cherkasov, Dmitry (GenoVoxx 200502) |
n. a. |
GenoVoxx GmbH |
Germany |
| Cheruvu, Pavan (Roivant 201806 CEO of Axovant Sciences) |
Chief Executive Officer (CEO) |
Sio Gene Therapies Inc. (Nasdaq: SIOX) |
United States (USA) |
| Cheung, Tracy (Consilium Strategic Communciations 202205– Partner before Compass Pathways + Amersham + GE Healthcare) |
Public Relations Manager / Investor Relations Manager |
ICR (Group) |
United Kingdom (GB) |
| Chhaya, Mohit (BellaSeno 202007 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
BellaSeno GmbH |
Germany |
| Chiam, Maria (Go To Market Consulting Inc 201309 Founder) |
Company Founder |
Go To Market Consulting Inc. |
United States (USA) |
| Chicca, Andrea (Synendos Therapeutics 202011 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Synendos Therapeutics AG |
Switzerland |
| Chickosky, John (Natrix Separations 201708 CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Canada |
| Chiesi, Antonio (HansaBioMed Life Sciences OÜ 201705 Managing Director + Exosomics Siena SpA 201705 CEO) |
Managing Director |
Lonza (Group) |
Estonia |
| Chiesi, Paolo (Chiesi 201309 VP + RnD Director) |
Research & Development Manager |
Chiesi (Group) |
Italy |
| Chiha, Slim (Prosion 202308 Managing Director (CEO) + Co-Founder) |
Chief Executive Officer (CEO) |
Prosion GmbH (Prosion Therapeutics) |
Germany |
| Chilian, Bruno (TRI Thinking Research Instruments 202205 Managing Partner) |
Managing Partner |
TRI Thinking Research Instruments GmbH |
Germany |
| Chiriano, Gianpaolo (Mirabaud 202209 Managing Director) |
Managing Director |
Mirabaud Bank |
Switzerland |
| Chiswell, David (Kymab 201604–201904 CEO before interim CEO since early 2015 before Nabriva + Albireo + CAT + Amersham) |
Chief Executive Officer (CEO) |
Sanofi (Group) [since May 2011] |
United Kingdom (GB) |
| Chiu, Michael (Erbi Biosystems 2022 CEO joined 2018 as COO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
United States (USA) |
| Chiva, Cristina (Centre for Genomic Regulation CRG 201201 Acting Manager of CRG/UPF Proteomics Unit) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
Centre for Genomic Regulation (CRG) (Spain) |
Spain (España) |
| Cho, Jeong-Woo (SK Group 201902 CEO of SK Biopharmaceuticals) |
Chief Executive Officer (CEO) |
SK Group (Group) |
|
| Cho, Sung Hee (FCB-Pharmicell 201010– Managing Director of Pharmicell Europe GmbH) |
Managing Director |
RNL Bio (Group) |
Germany |
| Chornet, Nicolas (Moderna 202009 SVP International Manufacturing Europe) |
Production Manager |
Moderna (Group) |
Switzerland |
| Choudhary, Asheesh (Cargill 202105 Global Business Development Director Bioindustrial) |
Business Development Manager / Strategy Manager |
Cargill (Group) |
United States (USA) |
| Choulika, André (Cellectis 200701 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cellectis (Group) |
France |
| Choveaux, David (Sparta Biodiscovery 202309 Business Development + Operations) |
Business Development Manager / Strategy Manager |
Sparta Biodiscovery Ltd. |
|
| Chow, Hong (Merck (DE) 202110– Head of China + International for Healthcare before Roche + Bayer/Schering) |
Regional manager |
Merck (DE) (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 11 12 13 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
